Literature DB >> 23154253

Syphilis negatively influences the response to hepatitis C virus treatment in an HIV-infected patient.

Ellen H Nagami1, Arthur Y Kim, Rachel P Baden, Barbara H McGovern.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23154253      PMCID： PMC3985605     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN： 2161-5853


× No keyword cloud information.
  45 in total

1.  Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

Authors:  Fabrice Carrat; Firouzé Bani-Sadr; Stanislas Pol; Eric Rosenthal; Françoise Lunel-Fabiani; Asmae Benzekri; Patrice Morand; Cécile Goujard; Gilles Pialoux; Lionel Piroth; Dominique Salmon-Céron; Claude Degott; Patrice Cacoub; Christian Perronne
Journal:  JAMA       Date:  2004-12-15       Impact factor: 56.272

2.  Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

Authors:  Masao Honda; Akito Sakai; Tatsuya Yamashita; Yasunari Nakamoto; Eishiro Mizukoshi; Yoshio Sakai; Taro Yamashita; Mikiko Nakamura; Takayoshi Shirasaki; Katsuhisa Horimoto; Yasuhito Tanaka; Katsushi Tokunaga; Masashi Mizokami; Shuichi Kaneko
Journal:  Gastroenterology       Date:  2010-04-29       Impact factor: 22.682

3.  Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

Authors:  Michael T Dill; Francois H T Duong; Julia E Vogt; Stéphanie Bibert; Pierre-Yves Bochud; Luigi Terracciano; Andreas Papassotiropoulos; Volker Roth; Markus H Heim
Journal:  Gastroenterology       Date:  2010-11-25       Impact factor: 22.682

4.  Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response.

Authors:  Jama M Darling; Jeroen Aerssens; Gregory Fanning; John G McHutchison; David B Goldstein; Alexander J Thompson; Kevin V Shianna; Nezam H Afdhal; Michael L Hudson; Charles D Howell; Willem Talloen; Jacques Bollekens; Mieke De Wit; Annick Scholliers; Michael W Fried
Journal:  Hepatology       Date:  2011-01       Impact factor: 17.425

5.  Telaprevir for previously untreated chronic hepatitis C virus infection.

Authors:  Ira M Jacobson; John G McHutchison; Geoffrey Dusheiko; Adrian M Di Bisceglie; K Rajender Reddy; Natalie H Bzowej; Patrick Marcellin; Andrew J Muir; Peter Ferenci; Robert Flisiak; Jacob George; Mario Rizzetto; Daniel Shouval; Ricard Sola; Ruben A Terg; Eric M Yoshida; Nathalie Adda; Leif Bengtsson; Abdul J Sankoh; Tara L Kieffer; Shelley George; Robert S Kauffman; Stefan Zeuzem
Journal:  N Engl J Med       Date:  2011-06-23       Impact factor: 91.245

6.  Treponema pallidum elicits innate and adaptive cellular immune responses in skin and blood during secondary syphilis: a flow-cytometric analysis.

Authors:  Juan C Salazar; Adriana R Cruz; Constance D Pope; Liliana Valderrama; Rodolfo Trujillo; Nancy G Saravia; Justin D Radolf
Journal:  J Infect Dis       Date:  2007-02-05       Impact factor: 5.226

7.  Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors.

Authors:  Verónica Saludes; Maria Alma Bracho; Oliver Valero; Mercè Ardèvol; Ramón Planas; Fernando González-Candelas; Vicente Ausina; Elisa Martró
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

8.  Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a.

Authors:  Paola Nasta; Francesca Gatti; Massimo Puoti; Giuliana Cologni; Viviana Bergamaschi; Federica Borghi; Alessandro Matti; Antonella Ricci; Giampiero Carosi
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

9.  Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response.

Authors:  Peter Ferenci; Hermann Laferl; Thomas-Matthias Scherzer; Michael Gschwantler; Andreas Maieron; Harald Brunner; Rudolf Stauber; Martin Bischof; Bernhard Bauer; Christian Datz; Karin Löschenberger; Elisabeth Formann; Katharina Staufer; Petra Steindl-Munda
Journal:  Gastroenterology       Date:  2008-05-27       Impact factor: 22.682

10.  Interferon signaling and treatment outcome in chronic hepatitis C.

Authors:  Magdalena Sarasin-Filipowicz; Edward J Oakeley; Francois H T Duong; Verena Christen; Luigi Terracciano; Witold Filipowicz; Markus H Heim
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-08       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.